Sequoia Financial Advisors, LLC

Position in GRFS — Grifols SA

CIK 1599900 Akron, OH

Position in GRFS

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$245,591

-$73,139 QoQ

Shares Held

34,688

-12.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 164 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sequoia Financial Advisors, LLC holds $404,940,719 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	154,543	$185,363,525
2	AMGN	Amgen Inc	173,024	$62,655,450
3	JNJ	Johnson & Johnson	203,267	$51,623,719
4	MRK	Merck & Co., Inc.	292,117	$37,537,034
5	ABBV	AbbVie Inc.	94,884	$23,876,609
6	BMY	Bristol Myers Squibb Co	179,874	$10,364,339
7	PFE	Pfizer Inc	332,178	$7,998,846
8	GILD	Gilead Sciences, Inc.	58,662	$7,411,357

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$245,591	34,688	-12.7%	Shares	Sole	2026-07-17
2026-03-31	$318,730	39,742	+26.5%	Shares	Sole	2026-04-30
2025-12-31	$293,767	31,419	+3.3%	Shares	Sole	2026-02-03
2025-09-30	$302,813	30,403	+15.6%	Shares	Sole	2025-10-29
2025-06-30	$237,670	26,291	+0.2%	Shares	Sole	2025-07-25
2025-03-31	$186,495	26,230	+14.9%	Shares	Sole	2025-04-23
2024-12-31	$169,862	22,831	-0.4%	Shares	Sole	2025-08-08
2024-09-30	$203,609	22,929	+2.3%	Shares	Sole	2024-10-21
2024-06-30	$141,400	22,409	-0.7%	Shares	Sole	2024-07-15
2024-03-31	$150,780	22,572	-2.3%	Shares	Sole	2024-04-30
2023-12-31	$266,978	23,095	-1.3%	Shares	Sole	2024-01-26
2023-09-30	$213,903	23,403	+1.6%	Shares	Sole	2023-11-08
2023-06-30	$210,899	23,024	+7.8%	Shares	Sole	2023-08-08
2023-03-31	$157,378	21,354	-1.9%	Shares	Sole	2023-04-25
2022-12-31	$185,045	21,770	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.